Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma

Clinical trial NCT03541148 · COMPLETED

Trial details

NCT number: NCT03541148
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Melanoma, Stage II Malignant Cutaneous Melanoma Cutaneous Melanoma, Stage III

Start date: 2014-09-16
Primary completion: 2016-04-13
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.